An integrated approach to the treatment of infectious lesions of the upper respiratory tract in pediatric practice
Introduction . The article substantiates a comprehensive bioregulatory approach to the treatment and immunorehabilitation of infectious respiratory diseases of the upper respiratory tract in pediatric practice. Aim . To study the efficacy and tolerability of a bioregulatory drug in the complex treatment of children with infectious lesions of the upper respiratory tract. Materials and methods . A prospective single-center study was conducted, 63 children: the main group of 32 children, the bioregulatory drug Tonsilgon® N 14 days was included in the complex of generally accepted therapy; 31 – the control group, only a complex of generally accepted therapy providing an anti-inflammatory effect was carried out. The age of children was 3–5 (4.3 ± 0.37) and 6–12 (9.2 ± 1.48) years in equal numbers by gender. Verification of the pathogen was carried out upon admission: in the main group, group A β-hemolytic streptococcus was detected in 7 (21.87%) patients, in the control group – in 6 (19.35%) patients; In the main group, Ig to Chlamydophila pneumoniae and Mycoplasma pneumoniae were in 9 (28.12%) patients, in the control group – 8 (25.8%), systemic antimicrobial therapy was prescribed. Results . In the main group, on the 3rd day of examination, the treatment was assessed as highly effective in 21 (65.62%), effective in 10 (31.25%), and moderately effective in 1 (3.12%). On average, the effectiveness score for the group was 2.61 ± 0.14 points. Discussion. The broad spectrum of action, due to the diverse composition of the phytoimmunomodulator, has a stimulating effect on the activation of phagocytosis of macrophages and granulocytes, accelerating the elimination of pathogens, which is consistent with our data and with literature data. Conclusions . An integrated approach to the treatment of inflammatory diseases of the oral cavity in children with the inclusion of a bioregulatory drug has a beneficial effect on the course of the inflammatory process in the oropharynx and stimulates the body’s resistance.
Authors
- A. M. Zakirov (ORCID: https://orcid.org/0000-0003-1914-6731)
- A. A. Kadriev (ORCID: https://orcid.org/0000-0002-4875-507X)
- Х. М. Вахитов (ORCID: https://orcid.org/0000-0001-9339-2354)
- Р. А. Файзуллина (ORCID: https://orcid.org/0000-0002-7209-5737)
- Т. Б. Мороз (ORCID: https://orcid.org/0000-0002-0329-6383)
- A. I. Klyushkina (ORCID: https://orcid.org/0000-0003-0846-9842)
- A. G. Kadriev (ORCID: https://orcid.org/0000-0001-6895-4036)
- А. М. Закирова (ORCID: https://orcid.org/0000-0003-2976-0807)
- Е. L. Rashitova (ORCID: https://orcid.org/0000-0003-1450-8254)
- I. A. Sherifova
Institutions
- Kazan State Medical University (RU)
- Center for Children (US)
- Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU)
- City Clinical Hospital (RU)
Publication Details
- Journal
- Meditsinskiy sovet = Medical Council
- Published
- 2025-04-03
- DOI
- https://doi.org/10.21518/ms2025-027
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00